Site Menu
Search Close Search
Search Close Search
Page Menu

Cancer Nexus Blog

Read up on the Center's latest developments in cancer research, screening and prevention, as well as innovations in cancer detection and treatment.

  • excellence home grown.jpg
    Nov 14, 2022

    Accolades Once Again for the Cancer Research Office

    The Cancer Research Office is commended for their outstanding performance — once again!

    Read more
  • leukemia cell for patel SEO.jpg
    Oct 7, 2022

    Stopping Blood Cancer Before It Starts

    Shyam Patel, MD, PhD, explains a new method for detecting blood cancer before it takes root.

    Read more
  • bigstock-T-cells-for SEO.jpg
    Apr 12, 2022

    A Translational Approach to T cells: A Conversation with Jillian Richmond, PhD

    Jillian Richmond, PhD, discusses her T cell research and its application to diagnostics and therapies for lymphoma.

    Read more
  • Cancer-Research-Office.jpg
    Nov 17, 2021

    UMass CRO Receives Recognition for Outstanding Performance

    The UMass Cancer Research Office has received national recognition from ECOG-ACRIN for outstanding performance in clinical trials research

    Read more
  • adapt2quit.jpg
    Apr 23, 2021

    Innovative eHealth System Powered by Collective Intelligence Technology

    Personalized digital technology to address smoking-related health disparities developed by UMass Cancer Center researcher

    Read more
  • phase2-3-HPV-throat-cancer-Head-and-Neck-clinical-trial.jpg
    Apr 7, 2021

    UMass Cancer Center is One of Two Sites in Massachusetts Offering a Study of Maintenance Immunotherapy for Throat Cancer

    A Phase II/III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV-Positive OPSCC

    Read more
  • drammatic-phase3-clinical-trial.jpg
    Mar 16, 2021

    UMass Cancer Center offers a Phase III Study of Maintenance Drug Therapy for Multiple Myeloma

    Aims to determine if adding daratumumab results in improved overall survival, improved response and MRD negativity

    Read more